GHRS (GH Research plc) Net earnings per one share for the last twelve months

GH Research plc (GHRS) - corporate logo

The market for modern psychotherapeutic agents possesses colossal untapped potential. The rolling annual EPS YoY trend captures the current trajectory of business development, where -33.90 serves as the current parameter value. GH Research PLC (GHRS) is developing innovative molecules through partnerships with psychiatric centers, aiming for a patent monopoly and ultra-high margins following the approval of inhalation therapy.

ghres.com (GHRS) Net earnings per share (EPS TTM): for the period 02/11/2024 - 11/17/2026

GH Research Group - analytical breakdowns and key metrics (GHRS)

- market price and analyst price targets:
- business market valuation indicators:
Fundamental company valuation:GH Research Corp GHRS
Core merchandise of GH Research Corp

For GH Research PLC, which is developing innovations in psychoneurology, this indicator reflects the effectiveness of R&D monetization through net earnings per share dynamics. By analyzing the EPS YoY TTM growth value on the GURU.Markets platform, an investor can observe the rolling annual rate of change in real cash flows, allowing them to distinguish fundamental business growth from temporary market fluctuations and avoid value traps.